BI 3000202 / Boehringer Ingelheim - LARVOL DELTA

A Study in Healthy Men to Find Out How Blocking Certain Transport Proteins Affects the Amount of BI 3000202 in the Blood (clinicaltrials.gov) - P1 | N=16 | Recruiting | Sponsor: Boehringer Ingelheim | Not yet recruiting ➔ Recruiting

Enrollment open

A Study in Healthy Men to Find Out How Blocking Certain Transport Proteins Affects the Amount of BI 3000202 in the Blood (clinicaltrials.gov) - P1 | N=16 | Not yet recruiting | Sponsor: Boehringer Ingelheim

New P1 trial

A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE) (clinicaltrials.gov) - P2 | N=405 | Not yet recruiting | Sponsor: Boehringer Ingelheim

New P2 trial • Immunology • Inflammatory Arthritis • Lupus • Systemic Lupus Erythematosus

A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE) (clinicaltrials.gov) - P2 | N=405 | Recruiting | Sponsor: Boehringer Ingelheim | Not yet recruiting ➔ Recruiting

Enrollment open • Immunology • Inflammatory Arthritis • Lupus • Systemic Lupus Erythematosus

A Study to Test How BI 3000202 is Taken up in the Blood of People With and Without Liver Problems (clinicaltrials.gov) - P1 | N=44 | Recruiting | Sponsor: Boehringer Ingelheim | Not yet recruiting ➔ Recruiting

Enrollment open • Hepatology

1509-0004: A study to test whether different doses of BI 3000202 help people with systemic lupus erythematosus (SLE) (clinicaltrialsregister.eu) - P1/2 | N=7 | Not yet recruiting | Sponsor: Boehringer Ingelheim International GmbH, Boehringer Ingelheim Espana S.A.

New P1/2 trial • Immunology • Inflammatory Arthritis • Lupus • Systemic Lupus Erythematosus

A Study in Healthy Men and Women to Test How BI 3000202 is Taken up and Processed by the Body (clinicaltrials.gov) - P1 | N=12 | Completed | Sponsor: Boehringer Ingelheim | Active, not recruiting ➔ Completed

Trial completion

A Study to Test How BI 3000202 is Taken up in the Blood of People With and Without Liver Problems (clinicaltrials.gov) - P1 | N=44 | Not yet recruiting | Sponsor: Boehringer Ingelheim

New P1 trial • Hepatology

A Study to Test How Well BI 3000202 is Tolerated by People With Type 1 Interferonopathies (clinicaltrials.gov) - P1 | N=16 | Active, not recruiting | Sponsor: Boehringer Ingelheim | Recruiting ➔ Active, not recruiting

Enrollment closed • Interferonopathies • RNASEH2B • RNASEH2C • TREX1

A Study in Healthy Men and Women to Test How BI 3000202 is Taken up and Processed by the Body (clinicaltrials.gov) - P1 | N=12 | Active, not recruiting | Sponsor: Boehringer Ingelheim

Trial initiation date

A Study in Healthy Men and Women to Test How BI 3000202 is Taken up and Processed by the Body (clinicaltrials.gov) - P1 | N=12 | Active, not recruiting | Sponsor: Boehringer Ingelheim | Recruiting ➔ Active, not recruiting

Enrollment closed

1509-0014: A study in healthy people to test whether BI 3000202 affects how 2 other medicines (rosuvastatin and digoxin) are taken up in the body (clinicaltrialsregister.eu) - P1 | N=14 | Completed | Sponsor: Boehringer Ingelheim International GmbH

New P1 trial

1509-0010: A study in healthy men and women to test how BI 3000202 is taken up and processed by the body (clinicaltrialsregister.eu) - P1 | N=16 | Recruiting | Sponsor: Boehringer Ingelheim International GmbH

New P1 trial

A Study in Healthy Men and Women to Test How BI 3000202 is Taken up and Processed by the Body (clinicaltrials.gov) - P1 | N=16 | Recruiting | Sponsor: Boehringer Ingelheim | Not yet recruiting ➔ Recruiting

Enrollment open

A Study in Healthy People to Test Whether BI 3000202 Affects How 2 Other Medicines (Rosuvastatin and Digoxin) Are Taken up in the Body (clinicaltrials.gov) - P1 | N=14 | Completed | Sponsor: Boehringer Ingelheim | Active, not recruiting ➔ Completed

Trial completion

A Study in Healthy Men and Women to Test How BI 3000202 is Taken up and Processed by the Body (clinicaltrials.gov) - P1 | N=16 | Not yet recruiting | Sponsor: Boehringer Ingelheim

New P1 trial

A Study in Healthy People to Test Whether BI 3000202 Affects How 2 Other Medicines (Rosuvastatin and Digoxin) Are Taken up in the Body (clinicaltrials.gov) - P1 | N=14 | Active, not recruiting | Sponsor: Boehringer Ingelheim | Recruiting ➔ Active, not recruiting

Enrollment closed

A Study in Healthy People to Test Whether BI 3000202 Affects How 2 Other Medicines (Rosuvastatin and Digoxin) Are Taken up in the Body (clinicaltrials.gov) - P1 | N=14 | Recruiting | Sponsor: Boehringer Ingelheim | Not yet recruiting ➔ Recruiting

Enrollment open

A Study in Healthy People to Test Whether BI 3000202 Affects How 2 Other Medicines (Rosuvastatin and Digoxin) Are Taken up in the Body (clinicaltrials.gov) - P1 | N=14 | Not yet recruiting | Sponsor: Boehringer Ingelheim

New P1 trial

A Study to Test How Well BI 3000202 is Tolerated by People With Type 1 Interferonopathies (clinicaltrials.gov) - P1 | N=18 | Recruiting | Sponsor: Boehringer Ingelheim | Not yet recruiting ➔ Recruiting

Enrollment open • Interferonopathies